Related Experiment Video
Updated: Dec 29, 2025

The In ovo CAM-assay as a Xenograft Model for Sarcoma
Published on: July 17, 2013
An uncommon presentation of a cutaneous angiosarcoma
Nicholas O Wilssens1, Margot Den Hondt1, Jolien Duponselle1
1Department of Plastic & Reconstructive Surgery, University Hospitals, KU Leuven, Leuven, Belgium.
Cutaneous angiosarcoma (cAS) is a rare vascular tumor often misdiagnosed. This case highlights diagnostic challenges and the aggressive nature of cAS, emphasizing the need for advanced diagnostics.
Area of Science:
- Oncology
- Dermatology
- Pathology
Background:
- Cutaneous angiosarcoma (cAS) is a rare, aggressive vascular tumor primarily affecting the head and neck.
- Delayed diagnosis is common due to insidious onset and varied presentations, leading to poor patient outcomes.
Observation:
- An 88-year-old woman presented with a persistent retro-auricular lesion initially mimicking a hematoma.
- Initial histopathology and imaging were inconclusive for malignancy, showing benign features with hemorrhage.
- Rapid lesion expansion prompted further biopsies, revealing MYC oncoprotein expression confirming angiosarcoma.
Findings:
- Immunohistochemistry, specifically MYC oncoprotein detection, was crucial in diagnosing angiosarcoma after initial misleading histology.
- The tumor's size and location precluded surgical resection, and radiotherapy yielded minimal response.
Implications:
- This case underscores the diagnostic difficulties in cutaneous angiosarcoma, where histology and imaging can be deceptive.
- Advanced immunohistochemical markers are vital for accurate cAS diagnosis.
- Treatment challenges in the head and neck region necessitate exploring alternative therapeutic strategies for advanced cAS.
More Related Videos
06:15Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024